New Lancet Commission on Breast Cancer: Transforming breast cancer care globally

Apr 16 2024ABC Global Alliance Over the past two years, the international multidisciplinary group of experts, including Dr Fatima Cardoso, president of the Advanced Breast Cancer Global Alliance, has worked to transform the breast cancer care landscape. Supported and funded in part by the ABC Global Alliance, the commission has led debate around key issues, supported pilot studies, culminating it its landmark report advocating for six crucial areas for change.

Patients living with metastatic/advanced breast cancer have long suffered from stigma, misconceptions, and abandonment not just from society in general but also from healthcare providers and patient advocacy groups. There is an urgent need for change in the way metastatic breast cancer is understood and managed. With this change, it will be possible to treat most, alleviate suffering for all, and forget no-one living with MBC/ABC.

The report also stresses the importance of improving communication with patients, stating all healthcare professionals in the world should receive training in communication skills to allow them to better involve patients in all stages of cancer care. The new Lancet Commission on Breast Cancer started to work in 2021 with the commitment to raise the standard of breast cancer care and to close the equity gap that exists between and within countries. The recommendations to face the urgent challenges for breast cancer patients will be released this Tuesday, April 16, at 2 pm, in an online session.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Breast Cancer Now funds researchers to investigate targeted radiotherapy for metastatic breast cancer in the brainResearchers are trialing a new type of targeted radiotherapy to treat secondary breast cancer tumors in the brain, thanks to new funding from Breast Cancer Now.
Source: NewsMedical - 🏆 19. / 71 Read more »

Lancet Commission predicts sharp increase in global prostate cancer casesCases of prostate cancer are projected to double from 1.4 million per year in 2020 to 2.
Source: NewsMedical - 🏆 19. / 71 Read more »

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genesCell lines are an important in vitro model in breast cancer research. A team around biochemist Dr. Sonja Eberth and bioinformatician Dr.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancerA team of researchers from Hiroshima University has discovered a molecule that promotes the production of cancer cells. This molecule may prove to be a potential therapeutic target in the treatment of triple-negative breast cancer, an aggressive form of breast cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

Women with Incurable Breast Cancer Call for Approval of Life-Extending DrugTHREE women with incurable breast cancer say their lives would be otherwise longer had the NHS approved a breast cancer drug. The drug was deemed too expensive by the National Institute for Health and Care Excellence (Nice) to treat HER2-low secondary breast cancer in England - around 1,000 women per year, according to Breast Cancer Now.
Source: TheSun - 🏆 64. / 61 Read more »

Lancet report highlights the future landscape of prostate cancerAnnual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% to almost 700,000 over the same timeframe – mainly among men in low- and middle-income countries.
Source: NewsMedical - 🏆 19. / 71 Read more »